Cantor expects the visibility of Celldex's pipeline to increase this year, mitigating the stock's risk. The firm maintains a Buy rating on the shares.
U.S. Markets open in 4 hrs 17 mins
S&P Futures
2,689.25-3.75(-0.14%)Dow Futures
24,585.00-52.00(-0.21%)Nasdaq Futures
6,758.25-21.75(-0.32%)Russell 2000
1,573.82-9.74(-0.62%)Crude Oil
68.36+0.07(+0.10%)Gold
1,343.80-5.00(-0.37%)Silver
17.11-0.12(-0.72%)EUR/USD
1.23-0.00(-0.31%)